美國新投資限制會否令中國生物科技授權交易熱潮添變數?

英文原標題：Could new US investment curbs complicate China’s biotech licensing surge?

英文原摘要：Chinese biotech firms face fresh headwinds in their global expansion as Washington’s proposed outbound investment restrictions threaten to disrupt deal structures, even though drug licensing agreements remain untouched for now, analysts say. The US Treasury Department’s draft rules released last wee